PRESS RELEASE published on 12/06/2023 at 15:30, 9 months 14 days ago Brands Highly Prioritize Authenticity in Voice Over, Voices Report Finds Voices, the world's leading voice over marketplace, published their 2024 Audio Trends Report analyzing the state of voice over and audio. It reveals a growing engagement with AI tools and a heavy emphasis on authenticity in content creation in 2024 Voice Over Marketplace 2024 Audio Trends Report AI Voices Authenticity In Content Creation Voice Over Usage
PRESS RELEASE published on 11/22/2023 at 15:50, 9 months 28 days ago Voices Promotes Managed Services Offerings
PRESS RELEASE published on 08/23/2023 at 16:30, 1 year ago Voices Podcast Report Finds 48% of Podcast Listeners Have Purchased a Podcast-Advertised Product
Published on 09/20/2024 at 23:40, 5 hours 36 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 5 hours 46 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 6 hours 16 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 6 hours 46 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 7 hours 1 minute ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 6 hours 17 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 8 hours 16 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 9 hours 1 minute ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 9 hours 26 minutes ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 9 hours 29 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 11 hours 36 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 11 hours 36 minutes ago Mise à disposition du Rapport Financier Semestriel 2024